moxalactam has been researched along with E coli Infections in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (86.67) | 18.7374 |
1990's | 3 (10.00) | 18.2507 |
2000's | 1 (3.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daly, JM; Duff, M; Freeman, TA; Fuortes, M; Hilbert, DW; Matsuda, T; Stapleton, PP | 1 |
Bayer, AS; Kim, KS; Manocchio, M | 1 |
Leimbrock, C; Pranada, F; Pusztai-Markos, Z | 1 |
Denson, S; Kaplan, SL; Mason, EO; Pickering, LK; Ramos, OM | 1 |
Gootz, TD; Martin, RR; Moellering, RC; Perkins, RL; Sanders, CC; Sanders, WE; Strike, DG | 1 |
Beskid, G; Cleeland, R; Grimm, LM; McCracken, GH; Nelson, JD; Schaad, UB | 1 |
Carbon, C | 1 |
Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
Arensman, JB; Harris, RW; Moore, WL; Rissing, JP | 1 |
Buccini, F; Cherubin, C; Eng, RH; Smith, SM | 1 |
Cherubin, CC; Cleri, D; Corrado, ML; Gombert, M; Landesman, SH | 1 |
McCracken, GH; Schaad, UB; Thomas, ML; Threlkeld, N | 1 |
Goldstein, E; Hoeprich, PD; Nolan, SM; Olson, DA | 1 |
Aziz, MT; Kumar, A | 1 |
Smith, AL | 1 |
Asano, O; Christ, WJ; Dubuc, GR; Gavin, WE; Hawkins, LD; McGuinness, PD; Mullarkey, MA; Perez, M; Robidoux, AL; Wang, Y | 1 |
Katoh, H; Nagamachi, Y; Shiojima, M; Takenoshita, S; Tsukada, K | 1 |
Katoh, N; Miyake, K; Ohshima, S; Ono, Y | 1 |
Broner, CW; Fairclough, D; Hildner, WK; Rehg, JE; Schonbaum, GR; Shenep, JL; Stidham, GL; Stokes, DC | 1 |
Danziger, LH; Ferron, JL; Gauderer, MW; Gordon, N; Hau, T; Stellato, TA | 1 |
Brister, S; Brown, RA; Chiu, RC; Fradet, G; Mulder, DS; Prentis, J; Richards, GK | 1 |
Cherubin, CE; Eng, RH | 1 |
Carbon, C; Contrepois, A; Garaud, JJ; Meulemans, A; Mohler, J; Pangon, B; Vallois, JM | 1 |
Hirai, Y; Imamura, K; Kumasaka, Y; Nakahata, H; Senda, H; Suzuki, I; Takebe, K | 1 |
Barton, RP; Mogan, KA; Shenep, JL | 1 |
Frommelt, L; Teichmann, W; Wittmann, DH | 1 |
Aswapokee, N; Aswapokee, P; Kobwantanakun, S; Pruksachartvutti, S | 1 |
Hughes, JD; Nichols, C; Sanburg, AL | 1 |
Karlaganis, G; Nielsen, J; Schaad, UB; von Hattingberg, HM | 1 |
Kollée, LA; Muytjens, HL | 1 |
2 review(s) available for moxalactam and E coli Infections
Article | Year |
---|---|
Neonatal bacterial infection.
Topics: Antigens; B-Lymphocytes; Bacterial Infections; Chemotaxis, Leukocyte; Complement System Proteins; Cross Infection; Digestive System; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Maternal-Fetal Exchange; Meningitis; Methicillin; Moxalactam; Neutrophils; Penicillin G; Permeability; Phagocytosis; Pregnancy; Sepsis; Streptococcal Infections; T-Lymphocytes | 1982 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
2 trial(s) available for moxalactam and E coli Infections
Article | Year |
---|---|
[Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Escherichia coli Infections; Female; Focal Infection; France; Humans; Male; Moxalactam; Sepsis | 1983 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
27 other study(ies) available for moxalactam and E coli Infections
Article | Year |
---|---|
Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteriophages; Biological Therapy; Colony Count, Microbial; Endotoxins; Escherichia coli; Escherichia coli Infections; Female; Inflammation Mediators; Interleukin-6; Mice; Mice, Inbred BALB C; Moxalactam; Peritonitis; Survival Analysis; Tumor Necrosis Factor-alpha | 2005 |
Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
Topics: Animals; Animals, Newborn; Blood Bactericidal Activity; Cefotaxime; Escherichia coli Infections; Female; Meningitis; Microbial Sensitivity Tests; Moxalactam; Rats; Rats, Inbred Strains; Sepsis | 1984 |
Modulating effect of subinhibitory concentrations of compound LY 127935 on the virulence of Escherichia coli in the mouse.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred Strains; Moxalactam; Virulence | 1982 |
Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Citrobacter; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Moxalactam | 1982 |
Resistance to cefamandole: a collaborative study of emerging clinical problems.
Topics: Adult; Aged; Bacteroides Infections; beta-Lactamases; Cefamandole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Isoelectric Focusing; Male; Middle Aged; Moxalactam; Penicillin Resistance; Penicillins | 1982 |
Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.
Topics: Amdinocillin; Ampicillin; Animals; Cephalosporins; Cephamycins; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Kinetics; Male; Meningitis; Mice; Moxalactam; Penicillanic Acid; Rabbits | 1982 |
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |
Antimicrobial activity of latamoxef (moxalactam) against both Bacteroides fragilis and Escherichia coli in an intraperitoneal abscess model.
Topics: Abscess; Animals; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; Escherichia coli Infections; Moxalactam; Peritoneal Diseases; Rabbits | 1984 |
Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy.
Topics: Aged; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Infant; Infant, Newborn; Kinetics; Male; Meningitis; Microbial Sensitivity Tests; Moxalactam; Recurrence; Salmonella Infections | 1984 |
Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
Topics: Aged; Blood-Brain Barrier; Cephalosporins; Cephamycins; Escherichia coli Infections; Humans; Injections, Intravenous; Klebsiella Infections; Male; Meningitis; Middle Aged; Moxalactam | 1980 |
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
Topics: Bacterial Infections; Brain Abscess; Cephalosporins; Cephamycins; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Klebsiella Infections; Male; Meningitis; Moxalactam; Salmonella Infections; Serratia marcescens | 1981 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Adult; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Middle Aged; Moxalactam | 1981 |
Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
Topics: Agammaglobulinemia; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Cerebral Ventricles; Encephalitis; Escherichia coli Infections; Humans; Infant; Male; Meningitis; Moxalactam; Recurrence | 1981 |
E5531, a pure endotoxin antagonist of high potency.
Topics: Animals; BCG Vaccine; Cytokines; Drug Design; Endotoxins; Escherichia coli Infections; Gram-Negative Bacteria; Humans; In Vitro Techniques; Lipid A; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; Moxalactam; Nitric Oxide; Rhodobacter capsulatus; Tumor Necrosis Factor-alpha | 1995 |
Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Endothelins; Endotoxins; Escherichia coli Infections; Injections, Intraperitoneal; Moxalactam; Peritonitis; Prognosis; Rats; Rats, Wistar; Survival Analysis | 1993 |
Diffusion of cefmenoxime and latamoxef into prostatic fluid in the patients with acute bacterial prostatitis.
Topics: Body Fluids; Cefmenoxime; Escherichia coli Infections; Humans; Male; Middle Aged; Moxalactam; Prostate; Prostatitis | 1992 |
Effect of antioxidants in experimental Escherichia coli septicemia.
Topics: Animals; Antioxidants; Blood Pressure; Body Temperature; Chelating Agents; Drug Synergism; Endotoxins; Escherichia coli Infections; Heart Rate; Moxalactam; Rabbits; Sepsis; Shock, Septic; Superoxide Dismutase | 1989 |
Antibiotic prophylaxis in vascular surgery: pharmacokinetic study of four commonly used cephalosporins.
Topics: Animals; Aorta; Bacterial Infections; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dogs; Escherichia coli Infections; Kinetics; Moxalactam; Muscles; Staphylococcal Infections; Time Factors; Tissue Distribution; Vascular Surgical Procedures | 1986 |
Experience with the use of cefotaxime in the treatment of bacterial meningitis.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1986 |
Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.
Topics: Animals; Endocarditis, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Kinetics; Male; Microbial Sensitivity Tests; Moxalactam; Rabbits | 1986 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Topics: Animals; Blood Bactericidal Activity; Cefmetazole; Cefoperazone; Cefotetan; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Moxalactam; Neutrophils | 1986 |
Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.
Topics: Animals; Chloramphenicol; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Moxalactam; Rabbits; Sepsis | 1985 |
[Significance of the causative agent of infection for therapy of purulent peritonitis].
Topics: Abscess; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Clostridium Infections; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Middle Aged; Moxalactam; Peritonitis | 1985 |
Clinical efficacy and safety of a new oxacephem, moxalactam, in serious bacterial infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas Infections | 1985 |
Antibiotic-induced hypoprothrombinaemia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cefamandole; Escherichia coli Infections; Humans; Hypoprothrombinemias; Male; Moxalactam; Prothrombin Time; Urinary Tract Infections; Vitamin K | 1985 |
High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.
Topics: Child; Child, Preschool; Chromatography, High Pressure Liquid; Creatinine; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Kinetics; Male; Meningitis; Moxalactam | 1985 |
[Neonatal meningitis: is the combination ampicillin-gentamycin obsolete?].
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant, Newborn; Male; Meningitis; Microbial Sensitivity Tests; Moxalactam | 1985 |